LONDON (Alliance News) - Inspiration Healthcare Group PLC on Friday said the initial public offering process of its investee NeuroproteXeon Ltd continues, although it is expected to occur later than planned.
Inspiration Healthcare holds a 10% stake in drug delivery device company NeuroproteXeon, which in June announced its intention to float on the AIM market of the London Stock Exchange.
The IPO was expected to complete in the second half of 2018; however, Inspiration Healthcare believes this will no longer be the case.
Inspiration Healthcare shares were trading down 4.8% at 68.10 pence each on Friday.
Inspiration Hlt (IHC)